API Support for Late Clinical Phases and Commercial Manufacture
We are an industry-leading provider of clinical and commercial-scale API production services. Learn...
Rapid, robust analytical method development is integral to our drug substance and drug product...
Knowledge Center Small Molecules
Boost your knowledge
How to Design an HPAPI Plant
Watch this presentation from the 2022 HPAPI Virtual Summit to learn more about how to evaluate the...
Working as One to Advance Your HPAPI to Market
Creating the optimal pathway for your highly-potent small molecule drug candidate through each...
Pathway to success in Regulatory filings
24 May 2022
Lonza and Israel Biotech Fund Collaboration Framework Agreement to Support Biologics and Small...
9 May 2022
Lonza and ALSA Ventures Collaborate to Provide Development and Manufacturing Services for Biotech...
31 Mar 2022
Lonza Joins IPAC-RS, an International Consortium Advancing the Regulatory Science of Inhalation...
21 Mar 2022
Oasmia Signs Manufacturing Agreement with Lonza for Ovarian Cancer Drug Candidate Cantrixil
18 Jan 2022